Management of Suspected Drug Overdose
Immediately check responsiveness, activate emergency response systems without delay, and assess breathing and pulse for less than 10 seconds—prioritizing airway management and high-quality CPR over any pharmacologic intervention. 1, 2
Immediate Assessment and Stabilization
Primary Survey (First 60 Seconds)
- Check responsiveness and activate emergency response system immediately—do not delay activation while awaiting response to any intervention 3, 1, 2
- Assess breathing and pulse for less than 10 seconds 1, 2
- Obtain bedside glucose immediately to rule out hypoglycemia as a cause of altered mental status 4, 1
- Establish IV access and initiate continuous cardiorespiratory monitoring 4
Airway and Breathing Management
- For patients with a pulse but no normal breathing or only gasping: open the airway, reposition, and provide rescue breathing or bag-mask ventilation until spontaneous breathing returns 3, 1, 2
- Secure airway with endotracheal intubation if Glasgow Coma Scale ≤8 or protective airway reflexes are lost 4
- Continue standard BLS/ACLS measures if spontaneous breathing does not occur 3, 2
Cardiac Arrest Management
- For patients with no pulse: start high-quality CPR immediately with focus on compressions plus ventilation—standard resuscitative measures take priority over naloxone administration 3, 1, 2
- Use automated external defibrillator if available 2
- Naloxone can be administered along with standard ACLS care only if it does not delay high-quality CPR 3
Monitoring and Diagnostic Workup
Continuous Monitoring Parameters
- Respiratory rate (watch for <8 breaths/min), blood pressure, heart rate, oxygen saturation, and cardiac rhythm 4
- Serial ECGs to detect conduction delays or dysrhythmias (particularly important with lamotrigine or other cardiotoxic agents) 4
- Arterial or venous blood gas if respiratory depression is present to assess for hypoxemia and hypercarbia 4
Laboratory Studies
- Urine drug screen to identify co-ingestants, particularly opioids, alcohol, or other CNS depressants 4
- Serum acetaminophen and salicylate levels as part of standard overdose workup 4
- Comprehensive metabolic panel including electrolytes, renal function, and hepatic function 4
- Complete blood count 4
Opioid-Specific Management
Naloxone Administration Algorithm
- For patients with a definite pulse but no normal breathing or only gasping: administer naloxone while continuing standard BLS/ACLS care 3, 1, 2
- Naloxone can be administered via IV, IM, or subcutaneous routes 2
- Repeat doses at 2-3 minute intervals if respiratory function does not improve 2
- Goal is improved ventilatory effort, not full awakening—avoid excessive doses attempting to achieve full consciousness 1
- Monitor for improvement in respiratory status and level of consciousness after administration 2
Critical Caveat About Naloxone
- Naloxone is ineffective for non-opioid substances including xylazine, benzodiazepines, and other CNS depressants 3, 1
- Consider polysubstance overdose involving non-opioid substances if there is no response to naloxone 1
- Metabolic insults such as hypoxia or hypercarbia may contribute to non-response 1
Mixed Overdose Considerations
Benzodiazepine/Mixed Overdoses
- Flumazenil should NOT be routinely administered in mixed overdose scenarios due to multiple contraindications 4
- Standard supportive care with airway management and mechanical ventilation is preferred over flumazenil in mixed overdoses 4
Post-Resuscitation Observation
Minimum Observation Periods
- Observe patients who respond to naloxone for at least 2 hours after administration 1, 2
- Longer observation periods needed for patients suspected of taking long-acting opioids 1, 2
- Minimum observation period of 6-8 hours for benzodiazepine overdose, with longer periods if CNS depression persists 4
- Monitor for at least 2 hours after any intervention to assess for recurrent toxicity 4
- Continue observation until risk of recurrent toxicity is low and vital signs have normalized 4, 2
Repeated Dosing Strategy
- Repeated small doses or an infusion of naloxone beneficial if recurrent opioid toxicity develops 2
Disposition Criteria
ICU Admission Indications
- Respiratory depression requiring mechanical ventilation 4
- Persistent hemodynamic instability 4
- Cardiac dysrhythmias requiring continuous monitoring 4
Mandatory Pre-Discharge Requirements
- Psychiatric evaluation before discharge to assess suicide risk 4
- Vital signs normalized and risk of recurrent toxicity low 4, 2
Common Pitfalls to Avoid
- Never delay activating emergency response systems while awaiting response to naloxone or other interventions 3, 1
- Do not focus solely on opioid reversal when polysubstance overdose may be present 1
- Avoid administering excessive naloxone doses attempting to achieve full consciousness rather than adequate ventilation 1
- Do not assume clinical condition is due to opioid-induced respiratory depression alone—rescuers cannot be certain, particularly in first aid and BLS settings where pulse determination is unreliable 3